Articles by Abby Proch
-
The Best Advice I Ever Got: On The Job
5/22/2024
To commemorate Clinical Trials Day 2024, Clinical Leader tapped its community of clinical research professionals to share their insights — from individual efforts to partnership best practices to trial design and more.
-
The Best Advice I Ever Got: Patient Centricity
5/21/2024
To commemorate Clinical Trials Day 2024, Clinical Leader heard from those most invested in and concerned with keeping the patient as the focus.
-
The Best Advice I Ever Got: Networking
5/20/2024
To commemorate Clinical Trials Day 2024, Clinical Leader tapped its community of clinical research professionals to share their experiences with and praise for working with one another across the industry.
-
4 Things I Learned At SCOPE 2024
2/21/2024
The Summit for Clinical Ops Executives (SCOPE) ran from Feb. 11-4. Discover four things Executive Editor Abby Proch learned at the annual event.
-
4 Things I'm Looking Forward To At SCOPE 2024
2/1/2024
The Summit for Clinical Ops Executives (SCOPE) begins Feb. 11. Discover four things Executive Editor Abby Proch is looking forward to at the annual event.
-
What Clinical Trial Experts Think Will Happen With DCTs In 2024
12/28/2023
In part three of this preview of clinical trials trends, experts discuss the state of decentralized trials in all their permutations and muse on their fates as we enter 2024.
-
What Experts Think Will Happen With Patient Centricity In 2024
12/27/2023
In part two, experts discuss patient centricity themes, including diversity, equity, and inclusion (DEI) and precision medicine, in the clinical trials industry as we move into 2024.
-
What Clinical Trial Experts Think Will Happen With AI In 2024
12/26/2023
In part one of this preview of clinical trials trends for 2024, experts discuss the applications of AI in clinical research.
-
Age Diversity In Clinical Trials: Why It Matters
6/1/2023
Clinical trials are essential for evaluating the safety and efficacy of new treatments before they are approved for use by patients. However, a new report from the International Longevity Centre (ILC), in collaboration with RBW Consulting, highlights a significant problem in the clinical trial process: the underrepresentation of older adults.